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Conclusion: There was very good correlation between the presence, absence, and
spatial distribution of lipid pools as noted on OCT and NIRS imaging. Larger studies
are required to determine whether NIRS and OCT provide complementary information
for plaque characterization.
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Background: Reduction in the hyper-echogenicity characteristics of the ABSORB
scaffold has been demonstrated to be related to the recovery of vasoreactivity of the
scaffolded segment at 2 years. Subsequent changes in the platform design and
manufacturing processes lead to significant prolongation in the lumen support with a
new revision of the device . We sought to correlate the reduction in hyper-echogenicity
of the revised ABSORB with the recovery of vaso-reactivity of the scaffolded segment
during this time period.
Methods: All patients from the ABSORB trial, who underwent paired echogenicity
analyses and vasomotion testing at 6 (ABSORB Cohort B1) or 12 (ABSORB Cohort
B2) months follow-up, were included in the analysis. Vasoreactivity was calculated as
relative mean lumen diameter (MLD) changes from pre to post acetylcholine
administration
Results: Overall, 31 patients underwent paired IVUS derived echogenicity analyses
and vasomotion testing at 6 (n=14) and 12-month (n=17) follow-up respectively. The
reduction in hyper-echogenicity of the scaffolded segment in the acetylcholine test
group went from 20.04±10.01 % to 18.09±10.01%, (p=0.561) and from 23.89 ± 9.99
% to 18.16 ± 8.70 % (p=0.006) at 6 and 12 months, respectively. The changes in MLD
after administration of acethylcoline were 1% of vasodilation (p=0.405 ) and 4%
vasoconstriction (p=0.086) at 6 and 12 months, respectively. A significant relationship
between the changes in hyper-echogenicity and in MLD after acethylcoline
administration was demonstrated at 12 months (Spearman rho=-0.678, p=0.0154), but
not at 6 months (Spearman rho=-0.3778, p=0.252)
Conclusion: The reduction in hyperechogenecity of the scaffolded segment is
significantly correlated with the restoration of the vasomotor activities of a coronary
segment scaffolded by the ABSORB scaffold at a long-term follow-up. This is
consistent with the programmed loss of structural integrity of the scaffold at that time
point.
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Background: Anatomo-pathological data indicate that coronary plaques prone to
rupture and erosion tend to cluster within the proximal third of each coronary vessel.
Intracoronary NIRS is a novel method to detect lipid core plaques (LCP). We sought
to assess the spatial distribution of lipid core plaques (LCP) by means of near infra red
spectroscopy (NIRS) in coronary arteries.
Methods: Sixty-eight consecutive patients underwent NIRS imaging on a non culprit
coronary artery. The region of interest (ROI) was subsequently divided into 10-mm
segments from proximal to distal. The 2-mm long block chemogram value (probability
of LCP, ranging from 0–low probability- to 1 –high probability) was assessed per ROI
and per each 10-mm segment.
Results: Overall, the length of the ROI was 58.0±4.3 mm, subdivided into 10-mm
segments for a total of 392 analyzed segments. There was a progressive decrease of
LCP from proximal to distal in the various 10-mm segments (1st 0.41[0.34-0.48] vs.
2nd 0.35[0.29-0.42] vs. 3rd 0.37[0.30-0.43] vs. 4th 0.32[0.26-0.39] vs. 5th 0.26[0.20-
0.33] vs. 6th 0.26[0.19-0.33], p=0.011). While in LAD and in LCx, LCP tended to
cluster in the proximal segment (p<0.001 and p=0.001, respectively), in the RCA they
were evenly distributed along the artery (p=0.155). At logistic regression analysis,
distance from the ostium was the only independent predictor of LCP.
Conclusion: Lipid-core plaques, as detected by NIRS, cluster in the proximal segment
of the coronary arteries, in distribution similar to that observed in prior autopsy studies.
The distribution of LCP is similar to that of the culprit lesions of STEMI patients.
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Background: The long-term serial change of stent strut coverage and neointima
characteristics in DESs have not been fully investigated with OCT. This study tried to
evaluate the serial quantitative and qualitative changes of vascular response in drug
eluting stents (DES) at 9 months and 2 years using optical coherence tomography
(OCT).
Methods: The OCT was performed serially in 80 DESs of 76 patients at 9 months and
2 years after DESs implantation (sirolimus-eluting stent [SES], n=23; paclitaxel-eluting
stent [PES], n=20; zotarolimus-eluting stent [ZES], n=25, everolimus-eluting stent
[EES], n=12). Serial change of quantitative (neointimal thickness, stent strut coverage
and apposition at each strut) and qualitative characteristics were evaluated.
Results: The incidence of uncovered stent strut significantly decreases from 9 months
to 2 years follow-up (4.9 % to 2.6 %, p<0.001), but there was similar for malapposition
rate (1.0 % to 1.1 %, p=0.63) and incidence of intracoronary thrombi (10.0 % to 8.8
%, p=0.79). In qualitative evaluation, lipid laden neointima (13.8% to 26.3%, p=0.03)
and intimal disruption (13.8% to 33.8%, p=0.03) were more frequently detected at 2
years follow-up compared to 9 months follow-up.
Conclusion: This OCT study suggested that neointimal coverage improved from 9
months to 2 years, but prevalence of malappostion and thrombus was not changed
during extended follow-up. Additionally, the neoatherosclerosis including transforming
into lipid laden neointima might progress between 9 months and 2 year-follow period.
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Background: The bioresorbable vascular scaffold (BVS) has peculiar imaging
characteristics, like total translucency and radiolucency. We analyze the agreement
between QCA, IVUS and OCT in the BVS for length and minimum lumen area (MLA)
measurements immediately post-implantation and at 6 months.
Methods: Patients enrolled in the ABSORB cohort B1 study (NCT00856856)
underwent coronary angiography, IVUS and OCT immediately post BVS implantation
and at 6 months. Agreement between QCA edge detection (ED), QCA
videodensitometry (VD), IVUS and OCT regarding scaffold length and MLA was
analyzed through intraclass correlation coefficients and Passing-Bablock non-
parametric orthogonal regression.
Results: 45 patients were sequentially imaged. OCT estimates scaffold length
accurately compared to nominal length (95% CI of the difference: -0.15; 0.34 and -
0.13; 0.47mm for baseline and 6 months, respectively), whereas QCA incurs consistent
underestimation of the same magnitude at both time points (Pearson correlation =
0.806). IVUS yields low accuracy (95% CI of the difference: 1.04; 3.24 and -0.56;
2.65mm2 for baseline and 6 months, respectively), with several outliers and random
variability test-retest. MLA decreases substantially between baseline and 6 months in
QCA and OCT, but only minimally in IVUS (95% CI: 0.12, 0.52 mm2). ICCa and
Bland-Altman show poor agreement for MLA between the different imaging
modalities: worst agreement ED-IVUS post-implantation (ICCa 0.253); best agreement
IVUS-OCT at 6 months (ICCa 0.767). All the pairs deviated significantly from linearity
(p<0.01). Passing-Bablock non-parametric orthogonal regression showed constant and
proportional bias between IVUS and OCT.
Conclusion: OCT is the most accurate technique for measurement of scaffold length;
QCA incurs systematic underestimation (foreshortening) and IVUS is the most
inaccurate and unpredictable modality. This has implications for volumetric
B175JACC Vol 58/20/Suppl B  |  November 7-11, 2011  |  TCT Abstracts/POSTER/Intravascular Imaging: IVUS, OCT, Spectroscopy, and Other
P
O
S
T
E
R
S
www.JACC.TCTAbstracts2011
